Cure Alzheimer’s Fund and the National Institute of Mental Health (NIMH) are collaborating on a strategic initiative to accelerate the development of drugs and therapies for Alzheimer’s and related dementias—a significant unmet medical need. Viewers learned more about this topic during a live-streamed webinar with presenters Rudy Tanzi, Ph.D., chairman of Cure Alzheimer’s Fund Research Consortium, and Tim Armour, president and CEO of Cure Alzheimer’s Fund, along with moderator David Shenk.